Peter Caldwell, DPM
Podiatrist · Cedar Rapids, IANPI 1861479727
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (42.3%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Arthrex accounts for 71.4% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $3,661 and has fallen 89.6% since, to $382 in 2025.
Across 86 payments — averaging $88.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$5K
- Wardlow Enterprises$1K
- Stryker$583
- Arteriocyte Medical Systems, Inc.$311
- Zimmer Biomet$230
- AbbVie$26
- plus $9 from 1 others
What the payments were for
- Travel & lodging$1,94825%
- Food & beverage$2,45732%
- Education$3,23442%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 35 | $5,456 |
| Wardlow Enterprises | 15 | $1,024 |
| Stryker | 28 | $583 |
| Arteriocyte Medical Systems, Inc. | 2 | $311 |
| Zimmer Biomet | 3 | $230 |
| AbbVie | 1 | $26 |
| Orthofix Medical, Inc. | 2 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Magellan$214
How this compares
$7,639 in reported general payments places this provider in the 85th percentile of 94 podiatrist providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort | 35 | $1,965 |
| Methylprednisolone | 156 | $912 |
| Allopurinol | 22 | $694 |
| Terbinafine Hcl | 62 | $507 |
| Gabapentin | 20 | $488 |
| Celecoxib | 13 | $215 |
| Cephalexin | 63 | $211 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 34 | $174 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 26 | $171 |
| Doxycycline Monohydrate | 13 | $162 |
| Duloxetine Hcl | 12 | $136 |
| Meloxicam | 94 | $120 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 53 | $99 |
| Levofloxacin | 22 | $78 |
| Indomethacin | 14 | $73 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Cedar Rapids
- Michelle DoleCedar Rapids$5K
- Joseph KuklaCedar Rapids$3K
- Rodney DempewolfCedar Rapids$2K
- Paul DaytonAnkeny$9.4M
- Mindi DaytonAnkeny$333K
- Eric BarpWest Des Moines$149K
- Travis TidwellWaterloo$33K
- Eric TempleWest Des Moines$19K
- Eric JensenCarroll$17K
- Eric ReeseWest Des Moines$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.